Sponsor or institution
Clinical trials and research at Ractigen Therapeutics.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Ractigen Therapeutics. that are recruiting, at sites in 2 countries (most in Australia (1), China (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Evaluating RAG-17 for ALS patients with SOD1 mutation
This study is testing a new drug called RAG-17 to see if it is safe and effective for people with ALS who have a specific SOD1 gene mutation.
-
Evaluating RAG-01 for patients with bladder cancer who didn't respond to BCG therapy
This study is testing a new treatment called RAG-01 for people with bladder cancer who didn't get better after standard BCG therapy to see if it works and is safe.
Quick answers
How many clinical trials run by Ractigen Therapeutics. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Australia (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.